A significant breakthrough in cancer study is emerging with the use of VHH fragments to reactivate damaged p53. This crucial cancer inhibitor protein is frequently disabled in various kinds of tumors, causing https://one-bookmark.com/story21893365/mini-antibodies-revive-the-p53-protein-the-potential-hope-for-cancer-treatment